Genzyme, Daiichi allow Impax to launch a generic Welchol

06/30/2011 | Reuters

Generic-drug maker Impax Laboratories resolved a patent dispute with Genzyme and Daiichi Sankyo regarding diabetes pill Welchol. The settlement allows Impax to market its version on March 2, 2015, or earlier under certain conditions.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL